sponsored
PatientsVille.com Logo

PatientsVille

Edarbi Medical Research Studies

Up-to-date List of Edarbi Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Edarbi Medical Research Studies

Rank Status Study
1 Recruiting A Phase Ⅰa Study of Azilsartan Trimethylethanolamine in Healthy Volunteers
Condition: Health
Interventions: Drug: Azilsartan Trimethylethanolamine;   Drug: Placebo
Outcome Measures: To study the Pharmacokinetics of Azilsartan Trimethylethanolamine by assessment of drug concentration through blood sample analysis;   Number of participants with adverse reactions
2 Recruiting Effect of Azilsartan on Aldosterone in Postmenopausal Females
Condition: Hypertension
Interventions: Drug: Azilsartan medoximil;   Drug: Placebo
Outcome Measures: To evaluate the effect of an angiotensin receptor blocker (azilsartan medoximil) on blood pressure in postmenopausal females.;   To evaluate the effect of an angiotensin receptor blocker (azilsartan medoximil) on urinary aldosterone levels in postmenopausal females.
3 Recruiting Azilsartan Circadian and Sleep Pressure
Condition: Hypertension
Interventions: Drug: Azilsartan;   Drug: Amlodipine
Outcome Measures: Change in nocturnal systolic blood pressure level;   Efficacy
4 Recruiting A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R
Condition: Essential Hypertension Complicated by Type 2 Diabetes Mellitus
Interventions: Drug: Azilsartan;   Drug: Telmisartan
Outcome Measures: Change in insulin resistance index (HOMA-R);   Change in fasting blood glucose from the start of the treatment period at the end of the treatment period (Week 12);   Change in fasting insulin;   Change in of glycosylated hemoglobin (HbA1c);   HOMA-β;   Change in 1,5-AG;   Adverse events
5 Recruiting Azilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance "Hypertension Complicated by Diabetes "
Condition: Hypertension
Intervention: Drug: Azilsartan
Outcome Measures: Changes from baseline in blood pressure measured at the medical institution and at home;   Changes from baseline in pulse rate measured at the medical institution, HbA1c (National Glycohemoglobin Standardization Program [NGSP] value), and urinary albumin level (creatinine-adjusted value);   Changes from baseline in HbA1c (National Glycohemoglobin Standardization Program [NGSP] value) at the medical institution;   Changes from baseline in urinary albumin level (creatinine-adjusted value) at the medical institution;   Frequency of adverse events
6 Recruiting Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics
Condition: Hypertension
Intervention: Other: Sevoflurane/oxygen/air/nitrous oxide
Outcome Measures: Systemic Vascular Resistance Index (SVRI);   Heart Rate;   Systolic Blood Pressure;   Diastolic Blood Pressure;   Central Venous Pressure;   Cardiac Output (CO);   Cardiac Index (CI);   Stroke Volume Varriation;   Systemic Vascular Resistance

These studies may lead to new treatments and are adding insight into Edarbi etiology and treatment.

A major focus of Edarbi research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss Edarbi